C213130
DMT-2′O-Methyl-rC(ac) Phosphoramidite
configured for ABI
Synonym(s):
N-acetyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-methyl-cytidine, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
Select a Size
About This Item
biological source
non-animal source (no BSE/TSE risk)
Quality Segment
product line
Proligo Reagents
assay
≥99% (31P-NMR), ≥99.0% (reversed phase HPLC)
form
powder
technique(s)
oligo synthesis: suitable
impurities
≤0.1% single unspecified Impurity (reversed phase HPLC), ≤0.3% mC2 (reversed phase HPLC, Hydrolysate), ≤0.3% mC3 (reversed phase HPLC, DMT-rC(ac)me), ≤0.3% mC4 (reversed phase HPLC, DMT-rC(ac)me-Ac), ≤0.3% water content (Karl Fischer), ≤0.5% P(III) Impurities 100-169ppm (31P-NMR), ≤1.0% mC1 (reversed phase HPLC, DMT-rC(ac)me-DMT), ≤3% residual Solvent content
color
white to off-white
λ
conforms (UV/VIS Identity)
suitability
conforms to structure for H-NMR, conforms to structure for LC-MS
compatibility
configured for ABI
nucleoside profile
base: cytidine
base protecting group: acetyl
2' protecting group: methyl
5' protecting group: DMT
deprotection: standard
storage temp.
-10 to -25°C
SMILES string
P(N(C(C)C)C(C)C)(O[C@@H]1[C@H](O[C@H](C1OC)N5C=CC(=NC5=O)NC(=O)C)COC(c4ccc(cc4)OC)(c3ccc(cc3)OC)c2ccccc2)OCCC#N
InChI
1S/C42H52N5O9P/c1-28(2)47(29(3)4)57(54-26-12-24-43)56-38-36(55-40(39(38)52-8)46-25-23-37(44-30(5)48)45-41(46)49)27-53-42(31-13-10-9-11-14-31,32-15-19-34(50-6)20-16-32)33-17-21-35(51-7)22-18-33/h9-11,13-23,25,28-29,36,38-40H,12,26-27H2,1-8H3,(H,44,45,48,49)/t36-,38-,39?,40-,57?/m1/s1
InChI key
WNWUMIPFLOKTEZ-IXZONTHDSA-N
Still not finding the right product?
Explore all of our products under DMT-2′O-Methyl-rC(ac) Phosphoramidite
Storage Class
11 - Combustible Solids
wgk
WGK 2
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.